Kathryn E. Falberg - Insider Trading & Ownership

Entity
Individual
Location
C/O Axovant Sciences, Inc., 320 West 37 Th Street, 5 Th Floor, New York, NY
Summary
The estimated net worth of Kathryn E. Falberg is at least $17.2M dollars as of September 5, 2024. Kathryn E. Falberg is the Director of Trade Desk, Inc. and owns shares of Trade Desk, Inc. (TTD) stock worth about $14.4M. Kathryn E. Falberg is the Director of Arcus Biosciences, Inc. and owns shares of Arcus Biosciences, Inc. (RCUS) stock worth about $2.76M.
All Insider Reports
All Insider Reports

Ownership of Kathryn E. Falberg

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TTD Trade Desk, Inc. Director $14.4M -$23.2M -61.6% Aug 13, 2024
RCUS Arcus Biosciences, Inc. Director $2.76M Jun 6, 2024
NUVB, NUVB-WT Nuvation Bio Inc. Director Sep 3, 2024
TCDA Tricida, Inc. Director Jun 15, 2022
URGN UroGen Pharma Ltd. Director Jun 7, 2021

Insider Transactions Reported by Kathryn E. Falberg:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.